PLA2G12B and steatosis: The human GWAS data showing that noncoding polymorphisms in putative cis-regulatory regions at the PLA2G12B locus are associated with circulating triglyceride and cholesterol levels in humans suggests that modulating the level of PLA2G12B may be a strategy to produce a less atherogenic plasma lipid profile without the steatosis associated with a null allele.